UpdatesPress Release
Gland Pharma sealed a strategic CDMO partnership with a global firm for sterile injectables.
Gland Pharma LimitedGLAND · Filed with the exchange
This agreement covers 55 SKUs, targeting USD 90-100 million in annual revenue from 2029, significantly boosting long-term business visibility.
No comments yet. Be the first.